about
Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenaseTranslating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps--an open letter to world leadersFunctional effects of endothelial nitric oxide synthase genetic polymorphisms on haemorheological parameters in healthy human individuals.Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluidGenetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.Paeoniae Radix, a traditional Chinese medicine, and CYP2C9 activity.Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway.Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes.CYP2C9 genetic variants and losartan oxidation in a Turkish population.Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.5-Fluorouracil-induced coronary spasm: may inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause?Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.Disposition of a CYP2C9 phenotyping agent, losartan, is not influenced by the common 3435C > T variation of the drug transporter gene ABCB1 (MDR1).Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.Effect of raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats.Capecitabine-induced severe hypertriglyceridemia: report of two cases.Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients.The therapeutic effects of melatonin and nimodipine in rats after cerebral cortical injury.Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid.Relationship between genetic polymorphisms of drug efflux transporter MDR1 (ABCB1) and response to losartan in hypertension patients.Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.[μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].Association between ADH1C and ALDH2 polymorphisms and alcoholism in a Turkish sample.Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease.CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with SchizophreniaValidation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.The possible role of endothelin(s) in cyclosporine A preparations--induced contraction of guinea pig isolated gallbladder stripsPenetration of ofloxacin in human aqueous and vitreous humors following oral and topical administrationTamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patientsVariant alleles and genotypes of alcohol dehydrogenase 3 in a Turkish populationDifferential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patientsInhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patientsMultidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene
P50
Q24682914-69FD5DBA-B024-4CF8-B539-3BA4AC879150Q27003942-DF8F743D-B6C8-4F74-8261-33219170615DQ33729098-E16AE704-807B-4C73-8786-036C97363333Q35307603-0AA6503F-1215-403C-8184-1C9B9C25B4F7Q36054252-28CB3DBD-DB98-4CE5-9540-83AB80CDA04FQ40471212-23B1290A-4893-417C-A141-A7C8699E8D8CQ43874208-91C3E121-6929-47BC-9A50-6DD64B38B749Q44039719-99D415D0-0D29-4DD0-AA2A-4D3060092818Q44217867-F305556D-1153-4D9B-9DA1-553A7DAD3CD4Q44228860-EAA13B77-E91C-4C96-8965-65A6D1B68F24Q44396463-784B299A-8249-442D-98AF-FE4DC0B86CA7Q44432237-1AD89447-F437-4056-80F8-4D5CB2CD406BQ44481060-FB07531C-9D11-4A2D-B9E4-BD2AB7A3BD43Q44537597-2653488C-5480-44ED-A7F7-AEB30246412AQ44936830-37F24907-251E-4665-92E2-7EE2C841F522Q44962613-D41AA705-416F-408C-96C3-17EE677E00EBQ45081582-88A50BC0-9F55-4562-9B77-6D3455757FFAQ45415992-F19662FE-D4DA-42F3-99A8-FB13FF15FAADQ46347790-C02C30C3-4E4A-4EC4-B671-62B0862EE0C5Q46720073-F39B2EE3-3C0D-429D-A186-B530D2BAA607Q46747889-FC0B9BBD-B107-4AF9-AF34-C03E5D99BFB8Q46833280-2A2915D2-CE9D-4A34-A360-1F103113BAC7Q46877890-A98A7F34-C66A-4C2C-A0BF-8934E7EFF944Q46918393-AF5B5498-5367-4538-8CC7-15CB68C298A7Q48268236-FA2CAF66-432F-4647-9060-7E8141950B06Q49085183-FAD3C9C0-8558-4D69-B007-A4C3E1CB13F1Q51685559-826B455A-01EA-405F-BE9C-2DFE866ADD96Q51750499-46CC9667-339C-4235-83B0-7DFE0B8FD077Q53780716-8437EE36-728B-495B-9D31-0D16938C3784Q54186144-844F30CC-13DD-4E06-BA9D-9CFC33A1BF21Q54762811-7E282306-EC80-4C3D-879F-3B5BF6B6D02BQ57820328-E5F92F53-41DC-4C13-815A-06A3C131557EQ64923947-04C54BF4-3AF9-432B-A7D3-FCEC944BCD35Q77476490-BDFAE965-AC58-42ED-83A5-126D9FE8DC2CQ77737991-793B2122-26D1-4DE2-AE69-94B6FB390AC1Q79197991-1A8A88DA-8FB6-43FF-8443-2F06490D5AFDQ79793965-99AA2A32-1B44-4E69-8297-3B0AB7764B72Q79897884-6D91E79D-DD90-4B09-8BFC-A2A758714083Q80364929-7BB6A24E-C136-42DE-8976-6A8024681708Q81152062-85EAA5EC-2AD6-48BE-98CC-85191441735E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Umit Yasar
@ast
Umit Yasar
@en
Umit Yasar
@es
Umit Yasar
@nl
Umit Yasar
@sl
type
label
Umit Yasar
@ast
Umit Yasar
@en
Umit Yasar
@es
Umit Yasar
@nl
Umit Yasar
@sl
prefLabel
Umit Yasar
@ast
Umit Yasar
@en
Umit Yasar
@es
Umit Yasar
@nl
Umit Yasar
@sl
P1053
A-1602-2008
P106
P1153
6701527726
P21
P31
P3829
P496
0000-0001-6758-0335